Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
451 - 460 of 892 results
  • Abstract
    Gene x environment interactions in pathological aggression modify the expression and function of CB1 receptors: relevance to the comorbidity between antisocial behavior and cannabis use
    Antisocial behavior (AB) is a neuropsychiatric disorder characterized by inappropriate and often exaggerated aggressive and violent responses. Ample evidence has shown that the pathogenesis of aggression reflects the synergism of genetic and environment...
    Nov 16, 2016
  • Astrocytes Function as an Intermediate for Retrograde Endocannabinoid Signaling in the Suprachiasmatic Nucleus to Influence Circadian Clock Timing | eNeuro
    Highlighted Research Paper: [[Cannabinoid Signaling Recruits Astrocytes to Modulate Presynaptic Function in the Suprachiasmatic Nucleus. Lauren M. Hablitz, Ali N. Gunesch, Olga Cravetchi, Michael Moldavan and Charles N. Allen][2]. ][2] []: /lookup/doi/10.1523/ENEURO.0081-19.2020
    Jul 1, 2020 Rosalind S.E. Carney
  • Abstract
    Pharmacological profiles of novel ligands for cannabinoid receptors
    The development of novel cannabinoids not only contributes to the discovery of new and safer therapeutic interventions, but also to the elucidation of endocannabinoid system biology. A series of novel derivatives of Δ8-Tetrahydrocannabinol were synthesi...
    Nov 7, 2007
  • Abstract
    A synthetic cannabinoid, CP55940, inhibits LPS-induced cytokine production in a CB1-independent manner in rat cerebellar granule cells
    An inflammatory response plays important roles in diseases such as Alzheimer’s disease in central nervous system. Since it has been reported that cannabinoids derived from Marijuana suppress inflammatory responses, we attempted to examine the gene expre...
    Nov 7, 2007
  • Abstract
    Activation of CB1 cannabinoid receptors stimulates carbohydrate intake by inhibiting behavioural satiety sequence in pre-feed rats
    It is now well established that the endogenous cannabinoid system is critically involved in the control of feeding behaviour. Recent studies have shown that endogenous (anandamide and 2-AG) and exogenous (Δ9-THC) cannabinoids substantially increase feed...
    Nov 6, 2007
  • Abstract
    Endocannabinoid-signaling regulates development of sea urchin embryos
    Development of pre-implantation mammalian embryos is negatively impacted by prenatal exposure to exogenous cannabinoids, like THC, and by agents that perturb endogenous “anandamide (AEA) tone”. AEA is an agonist at mammalian CB1, CB2, TRPV1, and several...
    Nov 5, 2007
  • Abstract
    CANNABINOID RECEPTOR 1 (CB1) EXPRESSION INCREASES IN PONS AFTER REM SLEEP DEPRIVATION PLUS REBOUND.
    Effects of delta-9-THC, the most active of the psychoactive substances extracted from marijuana are mediated by cannabinoid receptors CB1R and CB2R. CB1R has a preferential distribution in central nervous system and may be mediating the marijuana effects on sleep, which include increase in subjective sleepiness, alpha waves in the EEG and slow wave sleep (SWS). We previously reported that sleep rebound after deprivation of total sleep increases CB1R expression. This study aims to analyze if this effect was mediated by Rapid eye movement sleep (REMS) or SWS deprivation. Twelve Wistar male rats were REMS deprivated using the flower pot for 24 hours (REMSD). Six of them were allowed to rebound for 2 hours (REMSD + R). As stress control, 11 rats were maintained 24 hours on a large platform (LP) and 5 were allowed to recover for 2 hours (LP + R). All rats were sacrificed at the same hour that control rats (n=6). Membrane enriched fractions of pons were analyzed by western blot using serum anti-CB1R. Results ind...
    Nov 5, 2002
  • Abstract
    CANNABINOID RECEPTOR 1 INCREASES WITH SLEEP REBOUND.
    Delta-9-THC, the most active of the psychoactive substances extracted from marijuana, binds to two types of cannabinoid receptors: CB1R and CB2R. The former has a preferential distribution in CNS and may be mediating the marijuana effects on sleep, which include increase in subjective sleepiness, alpha waves in the EEG and slow wave sleep. We previously reported that anandamide, an endogenous lipid that binds to CB1R increases SWS2 and Rapid Eye Movement Sleep (REMS). This study aims to analyze the effect of sleep deprivation and rebound on the CB1R expression in pons. Ten Wistar male rats were total sleep deprivated (TSD) by gentle manipulation for 24 hours. Five of them were allowed to rebound for two hours (TSD + R). They were sacrificed at the same hour that control rats (n=5). Fifteen rats were implanted with electrodes to analyze EEG and EMG. After surgery recover, ten of them, were REMS deprivated (REMSD) for 12 hours by analyzing their poligraphic records. Five of them were allowed to rebound for t...
    Nov 13, 2001
  • Abstract
    Eating stimulated by intra-PVN infusion of the endocannabinoid 2-AG is reversed by opioid receptor blockade.
    The endocannabinoid system is linked to the processes underlying eating motivation. Stimulation of central CB1 cannabinoid receptors induces feeding, while antagonists, such as rimonabant, suppress food intake. The endocannabinoid 2-arachidonoylglycerol (2-AG) stimulates feeding in rats following injection into the shell region of the nucleus accumbens. Similarly, anandamide stimulates feeding after infusion into the ventromedial nucleus of the hypothalamus. Given the central role of the paraventricular nucleus of the hypothalamus (PVN) in feeding and energy regulation, we determined the ability of 2-AG to stimulate eating when injected into this nucleus. The hyperphagic actions of the exogenous cannabinoid Δ9-tetrahydrocannabinol (THC) have been shown to be reversed by opioid receptor blockade. Moreover, subanorectic doses of the CB1 antagonist rimonabant and the general opioid receptor antagonist naloxone interact synergistically to suppress food intake. Thus, there is every indication that endogenous ca...
    Nov 14, 2005
  • Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines | Journal of Neuroscience
    The abuse of synthetic psychoactive substances known as “designer drugs,” or “new psychoactive substances” (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., “bath salts”) and synthetic cannabinoids (i.e., “spice”) are two types of NPS that have received substantial media attention. Although low recreational doses of bath salts or spice compounds can produce desirable effects, high doses or chronic exposure often leads to dangerous medical consequences, including psychosis, violent behaviors, tachycardia, hyperthermia, and even death. Despite the popularity of NPS, there is a paucity of scientific data about these drugs. Here we provide a brief up-to-date review describing the mechanisms of action and neurobiological effects of synthetic cathinones and cannabinoids.
    Nov 12, 2014 Michael H. Baumann
  • Previous
  • 44
  • 45
  • 46
  • 47
  • 48
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience